Hyperhidrosis

• FDA approval · 2023-02-27
  FDA Approved: GLYCOPYRROLATE — Original Application (Lifestar Pharma LLC)

  FDA approves Lifestar Pharma LLC's original ANDA for glycopyrrolate, a generic version of the drug.

• FDA approval · 2022-10-28
  FDA Approved: QBREXZA — Supplemental Application (Journey Medical Corporation)

  The FDA approved a supplemental application for QBREXZA (glycopyrronium) filed by Journey Medical Corporation. This action updates the produ…

• FDA approval · 2020-07-20
  FDA Approved: QBREXZA — Supplemental Application (Journey Medical Corporation)

  The FDA approved a supplemental application for QBREXZA (glycopyrronium) submitted by Journey Medical Corporation.

• FDA approval · 2017-06-23
  FDA Approved: GLYCOPYRROLATE — Original Application (Somerset Therapeutics, LLC)

  FDA approved the original application for a generic glycopyrrolate product from Somerset Therapeutics, LLC.